A new antibacterial agent can stop resistance development. Expectations are connected to linezolid, an oxazolidinone with a new pharmacological action
Sköld, O.
Lakartidningen 96(37): 3866-3867
1999
ISSN/ISBN: 0023-7205 PMID: 10522087 Document Number: 502627
Document emailed within 1 workday
Related Documents
Frost, B.M.; Valiant, M.E.; Dulaney, E.L. 1975: Antibacterial activity of 3-(1-methyl-5-nitro-2-imidazolylmethylideneamino)-2-oxazolidinone Journal of Applied Bacteriology 38(2): 177-184Weinberg, J.M.; Tyring, S.K. 2010: Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus Journal of Drugs in Dermatology: Jdd 9(10): 1198-1204
Cosnier, D.; Duchene-Marullaz, P.; Grimal, J.; Rispat, G.; Streichenberger, G. 1975: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (Tolonidine), a new antihypertensive agent. I. Action on blood pressure and heart rate Arzneimittel-Forschung 25(10): 1557-1561
Cosnier, D.; Labrid, C.; Rispat, G.; Streichenberger, G. 1975: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis Arzneimittel-Forschung 25(11): 1802-1806
Shinabarger, D.L.; Marotti, K.R.; Murray, R.W.; Lin, A.H.; Melchior, E.P.; Swaney, S.M.; Dunyak, D.S.; Demyan, W.F.; Buysse, J.M. 1997: Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions Antimicrobial Agents and ChemoTherapy 41(10): 2132-2136
Corelli, F.; Massa, S.; Stefancich, G.; Artico, M.; Panico, S.; Simonetti, N. 1984: Researches on antibacterial and antifungal agents. Ii - Synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(1-pyrrolidinyl)quinoline-3-carboxylic acid, a novel highly active, broad-spectrum antibacterial agent related to piromidic acid Il Farmaco; Edizione Scientifica 39(2): 95-109
Pankova, T.G.; Igonina, T.M.; Maĭer, T.V.; Salganik, R.I. 1996: Malaria parasite DNA and RNA changes connected with acquired resistance to chloroquine Molekuliarnaia Biologiia 30(1): 43-50
Bhuyan, B.K.; Smith, K.S.; Kelly, R.C.; Adams, E.G.; Abraham, I.; Sampson, K.E. 1993: Multidrug resistance is a component of V79 cell resistance to the alkylating agent adozelesin Cancer Research 53(6): 1354-1359
Wang, Y.Y.; Teicher, B.A.; Shea, T.C.; Holden, S.A.; Rosbe, K.W.; al-Achi, A.; Henner, W.D. 1989: Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance Cancer Research 49(22): 6185-6192
Mulla, M.S.; Thavara, U.; Tawatsin, A.; Chomposri, J.; Su, T. 2003: Emergence of resistance and resistance management in field populations of tropical Culex quinquefasciatus to the microbial control agent Bacillus sphaericus Journal of the American Mosquito Control Association 19(1): 39-46
Pasricha, A.; Bhalla, P.; Sharma, K.B. 1979: Evaluation of Lactic Acid as an Antibacterial Agent Indian Journal of Dermatology Venereology and Leprology 45(3): 159-161
Ben'kovich, B.I. 1991: The clinico-pharmacological analysis of the neurotropic action of psychostimulants and preparations with a metabolic type of action Farmakologiia i Toksikologiia 54(6): 66-69
Kuga, T.; Naito, J. 1974: Pharmacological action of 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolinone hydrochloride (doxapram). 2. Peripheral action Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(2): 165-174
Bartolo, M.; Di Folca, A.; Ricci, S. 1981: Plethysmographic researches on the beginning and duration of the pharmacological action of an isosorbide dinitrate drugs with prolonged action Giornale Italiano di Cardiologia 11(9): 1283-1287
Murata, M.; Tamai, I.; Sai, Y.; Nagata, O.; Kato, H.; Sugiyama, Y.; Tsuji, A. 1998: Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(11): 1113-1119
Gottmann-Lückerath, I. 1983: Clinico-experimental study on the start of the pharmacological action of an oral classical antihistaminic without and with delayed-action effect on the length of effect of the delayed-action type Die Medizinische Welt 34(18): 548-551
Van de Velde, M. 2006: Identification of the epidural space: stop using the loss of resistance to air technique! Acta Anaesthesiologica Belgica 57(1): 51-54
Botha, P.L.; Vorster, E.; Jordaan, C. 1991: In vitro activity of a new 'higher-lactam' antibacterial agent LY 193239 South African Medical Journal 79(6): 312-313
Hannan, A.; Batool, A.; Qamar, M.U.; Khalid, F. 2015: Propolis as an Antibacterial Agent against Clinical Isolates of Mdr-Acinetobacter Baumannii Journal of Ayub Medical College Abbottabad: Jamc 27(1): 216-219
Wagai, N.; Yoshida, M.; Takayama, S. 1992: Phototoxic potential of the new quinolone antibacterial agent levofloxacin in mice Arzneimittel-Forschung 43(3a): 404-405